Latest Technology Transfer News

Page 2 of 2
Percheron Therapeutics reports encouraging phase I clinical results for HMBD-002, confirming safety and early efficacy signals, while gearing up for a multi-arm phase II trial in 2026.
Ada Torres
Ada Torres
31 Oct 2025
Volt Resources has secured strategic funding and relocated its US operations to Alabama, advancing its graphite refinery ambitions while winning a key legal battle in Ukraine.
Maxwell Dee
Maxwell Dee
29 Oct 2025
Weebit Nano has reported a record quarter with A$7.3 million in customer receipts, securing three key product agreements and progressing critical technology milestones at leading semiconductor fabs.
Sophie Babbage
Sophie Babbage
21 Oct 2025
Weebit Nano has successfully taped out embedded ReRAM test chips at onsemi’s 65nm BCD fab, marking a critical step toward commercialising its low-power memory technology in automotive and AI markets.
Sophie Babbage
Sophie Babbage
6 Oct 2025
EOS has landed a landmark €71.4 million export contract for its 100kW High Energy Laser Weapon system, marking a significant advance in counter-drone defense technology amid escalating global drone warfare threats.
Maxwell Dee
Maxwell Dee
6 Aug 2025
Weebit Nano reports solid progress in Q4 FY25 with key technology milestones and its first product design license, backed by a strong cash position.
Sophie Babbage
Sophie Babbage
31 July 2025
Avenira Limited is advancing its Wonarah Phosphate Project with site mobilisation planned for mid-2025, backed by a $7.567 million capital injection from major shareholder Sichuan Hebang Technology. Operational milestones and regulatory approvals are progressing, positioning the company for first ore shipment in Q4.
Maxwell Dee
Maxwell Dee
30 Apr 2025
Avenira Limited has ended its licensing agreement with Aleees, freeing the company to focus on a phased development of its Wonarah Phosphate Project aimed at early revenue generation in late 2025.
Maxwell Dee
Maxwell Dee
12 Feb 2025
AdAlta has fast-tracked its cellular immunotherapy growth by signing two new term sheets for clinical-stage CAR-T products from Asia, pivoting to focus on in-licensing and clinical trials while winding down internal R&D on its antifibrotic drug AD-214.
Ada Torres
Ada Torres
6 Feb 2025